FULL POSTER SESSION ABSTRACTSleaf surface which is a prerequisite for the differentiation of infection structures. Consequently, msb2 mutants are attenuated in virulence (Lanver et al.,2010). The molecular mechanism leading to an activation of Msb2 and the downstream MAP kinase cascade is so far unknown. In yeast Msb2p isprocessed by the aspartyl protease Yps1p leading to an active cell-associated form and a secreted glycosylated part which has an inhibitory function in thefull length protein. In U. maydis Msb2 is also processed, but so far there is no evidence that this leads to an activation of surface sensing. Using a yeastmutant lacking five aspartyl proteases we could demonstrate that yeast Yps1p is able to cleave U. maydis Msb2. In addition, by using this heterologoussystem, two U. maydis aspartyl proteases were identified that were weakly able to cleave Msb2. The respective genes were deleted in the solopathogenicstrain SG200 and its Dmsb2 derivative expressing Msb2-HA-GFP. Possible phenotypic alterations in virulence as well as in Msb2 processing will bemonitored. In addition, a synthetic codon-adapted YSP1 gene has been introduced in the above-mentioned U. maydis strains to analyze the effects of anincrement in Msb2 cleavage on biological activity of the protein. Finally, the extracellular domain of Msb2 was subjected to a mutational analysis toidentify regions with a presumed positive regulatory function. Lanver, D., Mendoza-Mendoza, A., Brachmann, A. and Kahmann, R. (2010). Sho1 and Msb2-Related Proteins Regulate Appressorium Development in the Smut Fungus Ustilago maydis. The Plant Cell 22, 2085-2101.622. The U. maydis effector Pit2 inhibits maize cysteine proteases to suppress host defense. Andre Mueller 1 , Sebastian Ziemann 1 , Steffi Treitschke 2 ,Daniela Abmann 1 , Gunther Doehlemann 1 . 1) MPI for Terrestrial Microbiology, Karl-von-Frisch-Strabe 10, 35043 Marburg, Germany; 2) Fraunhofer ITEM-R,Biopark I, Josef-Engert-Strabe 9, 93053 Regensburg, Germany.The basidiomycete Ustilago maydis is the causal agent of smut disease in maize. Infected plants show tumor formation in all infected aerial parts asprominent symptoms. As a biotroph pathogen, U. maydis depends on living plant tissue and hence efficient suppression of plant immunity is required.Therefore, infectious hyphae secrete effector proteins that interfere with specific components of the plant immune system. One such secreted effectorproteinis Pit2 (Protein important for tumor-formation 2), which, in a previous study, was found to be essential for tumor formation in infected plants [1].Instead of tumors, necroses can be observed at infection sites indicating that plant defense and cell death reactions are triggered in Dpit2 infections [1].Using a combination of yeast-two-hybrid- and protease activity assays, we could show that Pit2 acts as an inhibitor of apoplastic plant cysteine proteaseswhose activity is directly linked with salicylic acid (SA)-associated plant defenses. Sequence comparisons with Pit2 orthologs from related smut fungiidentified a conserved 14 amino acid motif. Mutation of this motif leads to a loss-of-function of Pit2 and consequently to avirulence of U. maydis,suggesting that the protease inhibition by Pit2 is essential for plant infection. Moreover, synthetic peptides of the conserved motif show full activity asprotease inhibitor. Interestingly, expression of only this motif in U. maydis partially restores virulence of the Dpit2-mutant, substantiating the importantrole of this novel protease inhibitor in suppression of host immunity. [1] Doehlemann et al. 2011. Mol Micobiol 81: 751-766.623. The Ustilago maydis MAP Kinase signaling pathway: Identification of direct MAP kinase targets by phospho-peptide enrichment. Vikram Naik 1 ,Gerold J.M. Beckers 2 , Wolfgang Hoehenwarter 3 , Regine Kahmann 1 . 1) Max Planck Institute for Terrestrial Microbiology, Marburg, Germany; 2) PlantBiochemistry and Molecular Biology Group, RWTH-Aachen University, Aachen; Germany; 3) Department for Molecular Systems Biology, Faculty of LifeSciences, University of Vienna, Vienna, Austria.In the plant pathogenic fungus Ustilago maydis three MAP kinase modules have been identified mostly via their homology to genes in Saccharomycescerevisiae. The module consisting of the MAP kinase kpp2, the MAP kinase kinase fuz7 and the MAP kinase kinase kinase kpp4 controls pheromonesignalling and plays an essential role in mating and pathogenicity. Kpp2 is involved in filamentation and appressorium development while the MAP kinase,Kpp6, which also acts downstream of Fuz7, is required for appressorial penetration of plant epidermal cells. Our goal is to identify crucial virulence factorswhich act directly downstream of the MAP kinases Kpp2 and Kpp6. For this we generated a strain in which MAP kinase signaling can be induced byexpressing a constitutively active version of the MAPKK Fuz7 (Fuz7DD) under an inducible promoter in the presence or absence of kpp2 and kpp6. We thenused a two-step chromatographic procedure combining phosphoprotein enrichment using Al(OH)3-based metal oxide affinity chromatography (MOAC),followed by tryptic digest of enriched phosphoproteins, and TiO2-based MOAC for phosphopeptide enrichment. This enabled detection of low abundantphosphorylated peptides using LC-MS/MS and allowed direct identification and site-specific quantification of phosphorylated peptides that differentiallyaccumulated after MAP kinase activation in wild type and mutant cells. LC-MS/MS analysis of the phosphopeptide fraction obtained after the two-stepMOAC yielded 111 putative substrates of Kpp2 and Kpp6 MAP kinases in three replicate experiments. Of these 20 differentially phosphorylated proteinswere chosen for subsequent functional analyses. We are presently generating deletion mutants of these genes in compatible U. maydis strains that carrydifferent a and b alleles and in a solopathogenic strain. In addition, we are analysing the expression pattern of the chosen genes during the differentdevelopmental stages of U. maydis. Results on the role of these U.maydis genes on signaling and pathogenicity will be presented.624. See1 : A novel organ specific effector in the Ustilago maydis - maize interaction. Amey Redkar 1 , Christoph Hemetsberger 1 , Ziba Ajami-Rashidi 1 ,Virginia Walbot 2 , Gunther Doehlemann 1 . 1) Max Planck Institute for Terrestrial Microbiology, Department of Organismic Interactions, Karl von FrischStrasse 10, Marburg, 35043 Germany; 2) Department of Biology, Stanford University, Stanford, California. 94305-5020 USA.Ustilago maydis is a biotrophic smut fungus which infects all aerial organs of its host plant maize. The disease progression and development of infectionis by reprogramming of the plant tissue which ultimately results in formation of tumors. This tumor induction is likely being triggered by small secretedproteins by the fungus, so called effectors. Given the fundamental differences between the different maize organs that are colonized by U. maydis, wehypothesized that the fungus deploys organ specific effectors to manipulate physiology and development of specific host tissues (1). To further investigatethe role of individual organ specific effectors in modulating biotrophy, we in the present study identified a novel secreted protein, termed See1 (Seedlingefficient effector 1) that is strongly induced in seedling leaves but only weakly expressed in tassels and ears. U. maydis deletion mutants for see1 show astrong reduction of tumor formation in maize seedlings but not in floral tissues. Laser scanning confocal microscopy shows that the mutant hyphaesuccessfully enter the leaf tissue but might be blocked during pre proliferation stages in the mesophyll tissue of the leaf. Moreover, by labeling replicatingDNA by 5-ethynyl-2’-deoxyuridine (EdU) we observed that maize seedling colonized by Dsee1 do not show mitotic activity during infection, while celldivision in leaves is specifically induced in wildtype infected host cells. In contrast, the Dsee1 mutant induces normal tumor formation in tassels and alsoshows the stable cell division rate in colonized anthers. Overexpression of see1 causes a hypervirulent phenotype only in the vegetative parts of the tassel,which are not transformed to tumors in wild type infections. To localize See1 during the disease progression we are applying confocal microscopy with livecell imaging using mCherry-tagged See1 protein. Most importantly, we are aiming for the identification of see1 interaction partners to link the observedphenotypes with its molecular function to understand its organ-specific function for U. maydis virulence. (1) Skibbe D*, Doehlemann G*, Fernandes J,Walbot V. (2010) Maize tumors caused by Ustilago maydis require organ-specific genes in host and pathogen. Science 328:89-92.625. Investigation of unconventionally secreted proteins in Ustilago maydis. Stefanie Reissmann 1 , Sina Krombach 1 , Florian Bochen 1 , Till Ringel 1 , SaskiaKreibich 1 , Thomas Brefort 1 , Kerstin Schipper 1,2 , Matthias Mann 3 , Regine Kahmann 1 . 1) Organismic Interactions, Max Planck Institute for Terrestrial274
FULL POSTER SESSION ABSTRACTSMicrobiology, Marburg, Hessen, Germany; 2) Heinrich Heine University Düsseldorf, Institute for Microbiology, Universitätsstrabe 1, 40225 Düsseldorf; 3)Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.Secreted fungal proteins play a crucial role during the biotrophic interaction between the smut fungus Ustilago maydis and its host plant Zea mays. Inthe last decade it has been well established that proteins without a signal peptide can also be targeted to the outside of the cell in an ER/ Golgiindependent manner. We want to identify such unconventionally secreted proteins in U. maydis and investigate their potential function as pathogenicityfactors. Our approach is based on affinity purification of tagged candidate proteins, detected in the apoplastic fluid of infected maize leaves. Four oftwelve candidate proteins tested so far could be detected in culture supernatants. One candidate protein, Um11938, displays 55 % amino acid similarity tothe human sterol carrier protein 2 (SCP2) and we were able to demonstrate that it co-localizes intracellularly with peroxisomes. Mammalian SCP2 isdetected in peroxisomes but also found in the cytoplasm. It interacts with a variety of phospholipids as well as cholesterol and has been implicated in nonvesicular cholesterol transport and in regulating lipid rafts (Schroeder et al., 2007). um11938 deletion strains of U. maydis are severely compromised invirulence and peroxisomal localization of Um11938 is required to fulfill its function as a pathogenicity factor. um11938 deletion strains display no growthdefect on minimal media supplemented with different fatty acids as sole carbon source, suggesting that the Um11938 protein is not involved in bona fideb-oxidation. The results of ongoing experiments aimed to differentiate whether the pathogenicity relevant function of Um11938 is performedextracellularly or within the fungal peroxisomes will also be presented.Schroeder F., Atshaves B.P., McIntosh A.L., Gallegos M., Storey S.M., Parr R.D., Jefferson J.R., Ball J.M. and Kier A.B. Sterol carrier protein-2: New roles inregulating lipid rafts and signaling, Biochim. Biophys. Acta 1771 (2007) 700-718.626. Identification of a key regulator for the developmental switch leading to sporogenesis in Ustilago maydis. Marie Tollot, Regine Kahmann.Organismic Interactions, MPI Marburg, Marburg, Hessen, Germany.Ustilago maydis is a biotrophic pathogen of maize. Its life cycle begins with the mating of two compatible haploid sporidia to form a dikaryotic infectiousfilament. After penetrating the plant cuticle, the dikaryon spreads inside the plant tissues and induces the formation of tumors. At a defined time ofdevelopment, the sporogenesis program begins in tumor tissue: the hyphae start to fragment into individual cells that eventually differentiate into matureteliospores. The isolation of several mutants affected in spore formation has shown that a tight regulation of the cAMP signaling pathway and the activityof two transcriptional regulators Hda1 and Rum1, potentially functioning in the same chromatin modifying complex, are required. We have identified anew regulator for the sporogenesis program of U. maydis. It belongs to a family of transcriptional regulators that are characterized by the presence of aWOPR DNA binding domain. The best studied member of this family is Wor1 from Candida albicans which plays a key role in the switch from the nonpathogenicto the pathogenic form of the fungus. The U. maydis wor1 homologue um05853, was deleted in the compatible haploid strains FB1 and FB2.The deletion mutants were able to mate and to infect maize as efficiently as the wild-type. However, although the tumor rate was similar, no spores couldbe detected in plants infected by the deletion mutants. Confocal microscopy of the mutant dikaryon revealed that hyphal fragmentation and consequentlyspore maturation were not occurring. The hyphae were still spreading at a time when the wild type dikaryon had already formed mature spores. To furtherinvestigate the role of um05853, we expressed the gene in a haploid strain where the filamentous program can be induced in axenic culture via expressionof a functional b-heterodimer. The cells failed to switch to filaments, started to enlarge and showed septation, with each section containing one nucleus.This result suggests that Um05853 is able to counteract the b function and trigger fragmentation. Preliminary results show that Um05853 mightdownregulate several b-dependent genes including the gene encoding the master regulator Rbf1. We are currently identifying targets of Um05853 using amicroarray approach and expect that these results will highlight how Um05853 controls spore formation.627. Genetic characterization of virulence in the Pyrenophora teres f. teres - barley pathosystem. Timothy L. Friesen 1,2 , Rachel A. Shjerve 2 , Justin D. Faris 1 ,Robert S. Brueggeman 2 . 1) Cereal Crops Research Unit, USDA-ARS, Fargo, ND; 2) Department of Plant Pathology, North Dakota State University, Fargo, ND.Pyrenophora teres f. teres is a necrotrophic fungal pathogen that causes net form net blotch (NFNB) on barley throughout the world. Several resistancesources have been identified but few are effective against all P. teres f. teres pathotypes, indicating that the pathogen has an arsenal of effectors that areinvolved in disease induction. Genetic analysis identified two barley genotypes, Rika and Kombar, that each harbor unique dominant susceptibility geneslocated at the centromeric region of barley chromosome 6H. P. teres f. teres isolate 15A is virulent on Kombar but avirulent on Rika whereas P. teres f.teres isolate 6A is virulent on Rika but avirulent on Kombar. Based on the necrotrophic effector model, 15A and 6A each secrete unique effectors that aredirectly or indirectly interacting with genes on chromosome 6H in Kombar and Rika, respectively. A linkage map was generated using a mappingpopulation developed from a sexual cross between 15A and 6A, and 118 progeny were phenotyped on barley genotypes Rika and Kombar. Two majorvirulence QTL derived from 15A contributed to virulence on Kombar, and two additional unique virulence QTL derived from 6A contributed to virulence onRika. All susceptibility loci in the host mapped to the same region on barley chromosome 6H. Therefore, it is likely that at least four necrotrophic effectorspresent throughout the P. teres f. teres genome are interacting with host susceptibility genes located in one region of barley chromosome 6H. Theseresults strongly indicate that the NFNB-barley compatibility is at least partially due to necrotrophic effector-host susceptibility gene interactions that resultin disease induction. Currently, we are using a genotype by sequencing (GBS) approach to generate a saturated map to identify candidate genes in the QTLregions in order to clone and characterize the effector genes involved in the NFNB interaction.<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 275
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130:
FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132:
FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134:
FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136:
FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138:
FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140:
FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142:
FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144:
FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146:
FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148:
FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150:
FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152:
FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154:
FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156:
FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158:
FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160:
FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162:
FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164:
FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166:
FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168:
FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170:
FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172:
FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174:
FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176:
FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204:
FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206:
FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208:
FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210:
FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212:
FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214:
FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216:
FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218:
FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220:
FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222:
FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224:
FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226:
FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228: FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230: FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232: FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234: FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236: FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238: FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240: FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242: FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244: FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246: FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248: FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250: FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252: FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254: FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256: FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258: FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260: FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262: FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264: FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266: FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268: FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270: FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272: FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274: FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276: FULL POSTER SESSION ABSTRACTSE.elym
- Page 277: FULL POSTER SESSION ABSTRACTSThe de
- Page 281 and 282: FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284: FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286: FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288: FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290: FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292: FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294: FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296: FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298: FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300: FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302: FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304: FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306: FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308: KEYWORD LISTABC proteins ..........
- Page 309 and 310: KEYWORD LISThigh temperature growth
- Page 311 and 312: AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314: AUTHOR LISTFrancis, Martin ........
- Page 315 and 316: AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318: AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320: AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322: AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324: LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326: LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328: LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni